SavedAdd your journal

Journals / Uluslararası Hematoloji-Onkoloji Dergisi / 2014 / Cilt: 24 - Sayı: 3

An Immune Thrombocytopenic Purpura-Like Picture Preceding Chronic Myelomonocytic Leukemia: A Case Series and Review of the Literature

Murat ALBAYRAK
Eylem ELİAÇIK
Berfu KORUCU
Ayşe IŞIK
Gürsel GÜNEŞ
Salih AKSU
Hakan GÖKER
Haluk DEMİROĞLU
Nilgün SAYINALP
İbrahim C. HAZNEDAROĞLU
Osman İ. ÖZCEBE
Yahya BÜYÜKAŞIK
Pages
213–216
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

ALBAYRAK, M., ELİAÇIK, E., KORUCU, B., IŞIK, A., GÜNEŞ, G., AKSU, S., GÖKER, H., DEMİROĞLU, H., SAYINALP, N., HAZNEDAROĞLU, İ. C., ÖZCEBE, O. İ., BÜYÜKAŞIK, Y. (2014). An Immune Thrombocytopenic Purpura-Like Picture Preceding Chronic Myelomonocytic Leukemia: A Case Series and Review of the Literature. Uluslararası Hematoloji-Onkoloji Dergisi, Cilt: 24 - Sayı: 3, 213–216. https://ajindex.com/articles/322924

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Saif MW, Hopkins JL, Gore SD. Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Lymphoma 43: 2083-2092, 2002.
  2. Enright H, Jacob HS, Vercellotti G, et al. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy. Br J Haematol 91: 403-408, 1995.
  3. Komrokji RS, Kulasekararaj AG, Al Ali NH, et al. Characteristics and outcome of myelodysplastic syndromes (MDS) patients with autoimmune disease. 55th ASH Annual Meeting and Exposition. New Orleans, LA. Oral Poster Abstract. Poster No: 746. December 7-10, 2013.
  4. Mainwaring CJ, Shutt J, James CM. Not all cases of idiopathic thrombocytopenic purpura [correction of pupura] are what they might first seem. Clin Lab Haematol 24: 261-262, 2002.
  5. Peker D, Padron E, Horna P, et al. A close association of history of autoimmunity with chronic myelomonocytic leukemia (CMML) in contrast to chronic myelogeneus leukemia (CML). 54th ASH Annual Meeting and Exposition. Atlanta, GA. Oral and Poster Abstract. Poster No: 1712. December 8-11, 2012.
  6. Mufti GJ, Figes A, Hamblin TJ, et al. Immunological abnormalities in myelodysplastic syndromes. I. Serum immunoglobulins and autoantibodies. Br J Haematol 63: 143-147, 1986.
  7. Marisavljevic D, Kraguljac N, Rolovic Z. Immunologic abnormalities in myelodysplastic syndromes: clinical features and characteristics of the lymphoid population. Med Oncol 23: 385-391, 2006.
  8. Ural AU, Kaptan K, Avcu F, et al. Chronic myelomonocytic leukemia developed 2 years after the onset of immune thrombocytopenic purpura like syndrome. Haematologia (Budap) 30: 221-224, 2000.
  9. Bizzoni L, Mazzucconi MG, Gentile M, et al. Idiopathic thrombocytopenic purpura (ITP) in the elderly: clinical course in 178 patients. Eur J Haematol 76: 210-216, 2006.
  10. Billström R, Johansson H, Johansson B, et al. Immunemediated complications in patients with myelodysplastic syndromes--clinical and cytogenetic features. Eur J Haematol 55: 42-48, 1995.
  11. Voulgarelis M, Giannouli S, Ritis K, et al. Myelodysplasiaassociated autoimmunity: clinical and pathophysiologic concepts. Eur J Clin Invest 34: 690-700, 2004.
  12. Koca E, Duman AE, Cetiner D, et al. Successful treatment of myelodysplastic syndrome-induced pyoderma gangrenosum. Neth J Med 64: 422-424, 2006.
  13. Steensma DP, Tefferi A, Li CY. Splenic histopathological patterns in chronic myelomonocytic leukemia with clinical correlations: reinforcement of the heterogeneity of the syndrome. Leuk Re